KRT News - Candlesense

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025

(NASDAQ:KRT) Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardio...

What is the anticipated timeline for regulatory approval, commercial launch, and reimbursement for aficamten, and what are the potential risks to that timeline? What are the comparative efficacy and safety profiles of aficamten versus existing HCM therapies such as mavacamten and beta‑blockers, and how might this influence market share? How will the MAPLE‑HCM data and the JACC publication affect Cytokinetics' valuation and short‑term stock volatility?

Clinical trials

10 days ago

Karat Packaging to Present at Lake Street’s 9th Annual Best Ideas Growth Conference, September 11

CHINO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT), a specialty distributor and manufacturer of disposable foodservice products and related items, today announced...

Investor

13 days ago

Kartoon Studios Delivers Fifth Consecutive Quarter of Revenue Growth; Q2 Revenue Surges 23% Year-Over-Year, Including Strong Streaming Performance and Operational Efficiency

G&A Expenses Fall Double Digits as Company Moves Toward Profitability in 2025

What is the guidance for Q3 and full-year revenue and earnings, and does it align with market expectations? How might changes in consumer streaming behavior impact KRT's future revenue streams? What risks could impede KRT's path to profitability, such as increased competition or higher content costs?

Earnings

27 days ago